Ebola virus antibodies found in people prior to 2018 DRC outbreak

NewsGuard 100/100 Score

Scientists found antibodies to Ebola virus in people up to a year before the 2018 Ebola virus disease outbreak began in the Eastern Democratic Republic of Congo, or DRC. This suggests that either early cases may have been missed or that exposure occurs more commonly than previously thought, according to a study led by the University of California, Davis.

The study, published today in the journal One Health Outlook, also documents the first detection of antibodies to Bombali ebolavirus in a person, showing that spillover of that virus from bats to humans has likely occurred. Scientists from the UC Davis One Health Institute and Columbia University discovered Bombali virus -- a sixth ebolavirus species -- in bats in Sierra Leone in 2018.

This study highlights that, yes, these are lethal diseases, but there's a range of severity -- not everyone who is exposed dies. Spillover doesn't always cause lethal outbreaks. To prevent outbreaks, we need a better understanding of what's happening between them. If you really are trying to understand how a virus works, you need to study it at all times, not just during an outbreak."

Tracey Goldstein, lead author, associate director of the One Health Institute at the UC Davis School of Veterinary Medicine

WOMEN AT INCREASED RISK

For the study, scientists collected and tested biological samples from 272 people seeking care in the Rutshuru Health Zone of North Kivu Province over the year before the start of the outbreak that killed nearly 2,300 people. Antibodies, which indicate past exposure to a virus, were found in 10 percent of patients.

Scientists also administered questionnaires to patients to collect demographic and behavioral information, and to better understand their interactions with domestic animals and wildlife.

While people of both sexes and all ages tested positive for antibodies, women had a significantly increased risk of exposure. This is consistent with other studies and may be due to the larger role women play in preparing food and caring for livestock and sick family members.

"These findings are important for those of us who live in eastern Congo, because it shows that people may become exposed to Ebola virus without becoming ill," said Jean-Paul Kabemba Lukusa, the Gorilla Doctors' medical technologist who coordinated human surveillance for this study. "It helps reinforce the work we do to explain to people how important it is to limit direct contact with wild animals and to follow hygiene and safety best practices."

MOVING FORWARD

The study also demonstrates the need to address how humans come into contact with wildlife and the viruses they exchange.

Co-author Kirsten Gilardi directs the UC Davis Karen C. Drayer Wildlife Health Center and the Gorilla Doctors program, which provides veterinary care to wild mountain and eastern lowland gorillas in Rwanda, Uganda and DRC. As the region's country lead for the USAID PREDICT Project, Gorilla Doctors sampled both wildlife and humans for viruses that may be circulating among them.

"These findings suggest there are more spillover events than we realize," Gilardi said. "This may not happen once in a while and then the virus disappears. Preventing spillover means understanding and minimizing high-risk human-to-wildlife interactions."

Source:
Journal reference:

Goldstein, T., et al. (2020) Spillover of ebolaviruses into people in eastern Democratic Republic of Congo prior to the 2018 Ebola virus disease outbreak. One Health Outlook. doi.org/10.1186/s42522-020-00028-1.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Therapeutic potential of CD20 x CD3 bispecific antibodies